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Summary 
Intercellular adhesion molecule 1 (ICAM-1) is one of three immunoglobulin superfamily mem- 
bers that bind to the integrins lymphocyte function associated 1 (LFA-1) and Mac-1 on leukocytes. 
We have generated mice that are genetically and functionally deficient in ICAM-1. These mice 
have elevated numbers of circulating neutrophils and lymphocytes, as well as diminished aUogeneic 
T  cell responses and delayed type hypersensitivity. Mutant mice are resistant to lethal effects 
of high doses of endotoxin (lipopolysaccharide [LPS]),  and this correlates with  a significant 
decrease in neutrophil infiltration in the liver.  Production of inflammatory cytokines such as 
tumor necrosis factor ot or interleukin 1 is normal in ICAM-l-deficient mice, and thus protection 
appears to be related to a diminution in critical leukocyte-endothelial  interactions. After sensitization 
with D-galactosamine (D-Gal),  ICAM-l-deficient mice are resistant to the lethal effect of low 
doses of exotoxin (Staphylococcus  aureus enterotoxin B [SEB]), which has been shown to mediate 
its toxic effects via the activation of specific T cells. In this model, ICAM-l-mediated protection 
against SEB lethality correlates with a decrease in the systemic release of inflammatory cytokines, 
as well as with prevention of extensive hepatocyte necrosis and hemorrhage. ICAM-l-deficient 
mice sensitized with D-Gal,  however, are not protected from lethality when challenged with 
low doses of endotoxin (LPS).  These studies show that the different contribution of ICAM-1 
in the activation of either T cells or macrophages is decisive for the fatal outcome of the shock 
in these two models. This work suggests that anti-ICAM-1 therapy may be beneficial in both 
gram-positive and -negative septic shock, either by reducing T cell activation or by diminishing 
neutrophil infiltration. 
~  hesion receptors in the immune system control cell-cell 
interactions required for the activation of lymphocytes 
by foreign antigens, and for directing the migration and lo- 
calization of leukocytes. Leukocyte interaction with blood 
vessel walls and transendothelial migration are necessary for 
efficient defense against infections and are dysregulated in 
harmful inflammatory processes.  The interplay of adhesion 
molecules, namely the integrins, the Ig superfamily mem- 
bers, and the selectins  with chemoattractants and their re- 
ceptors, is thought to be critical for leukocyte extravasation. 
The/32 (CD18) subfamily of integrins expressed on leuko- 
cytes is composed of three members, LFA-1 (CDlla/CD18), 
Mac-1 (CDllb/CD18),  and p150,95  (CDllc/CD18)  (1, 2). 
LFA-1  is  expressed on all leukocytes, whereas Mac-1  and 
p150,95 are largely restricted to monocytes and granulocytes. 
LFA-1 binds to three Ig superfamily members, intercellular 
adhesion molecule (ICAM) 1 1, 2, and 3 (3). All three mol- 
ecules are found on leukocytes but only ICAM-1 and -2 are 
expressed on vascular endothelium (4-7). Mac-1 also binds 
to ICAM-1  (8,  9).  LFA-1 binds to domain 1 of ICAM-1, 
whereas Mac-1 binds to domain 3 (2, 10). Previous experi- 
ments have shown that the LFA-l-dependent adhesion of 
lymphocytes and monocytes to resting endothelial cells in 
vitro is about one-third dependent on interaction with ICAM-1 
and about two-thirds dependent on interaction with ICAM-2, 
reflecting the finding that ICAM-2 is expressed constitutively 
1 Abbreviations used in this paper: D-Gal, D-galactosamine;  DTH, delayed 
type hypersensitivity;  ES cell, embryonic  stem cell; ICAM, intercellular 
adhesion molecule; LAD, leukocyte  adhesion deficiency;  MLR, mixed 
lymphocyte  reaction; SEB, Staphylococcus  enterotoxin B. 
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However, upon  stimulation  by inflammatory  cytokines in 
vitro, ICAM-1 expression on endothelial cells is increased up to 
40-fold whereas ICAM-2 expression is unaffected (4-6,  11). 
Induction of ICAM-1 results in greatly increased binding of 
both lymphocytes and neutrophils to endothelial cells (9, 11). 
It has been hypothesized that leukocyte emigration from 
the circulation into surrounding  tissues involves sequential 
events that have been described as (a) initial rolling of leuko- 
cytes on inflamed vascular endothelium via selectin interac- 
tion with carbohydrate ligands;  (b) activation of leukocytes 
by chemoattractants;  (c) firm attachment to the blood vessel 
walls mediated by interactions between integrins  and their 
ligands; and (d) transendothelial  migration (3, 12,  13). Dis- 
ruption of this sequence at any step would presumably pre- 
vent leukocyte emigration and accumulation at inflammatory 
sites and would severely affect normal inflammatory responses. 
The critical role in inflammatory responses and immune func- 
tions  of 32  integrins,  and  of the  carbohydrate  ligands  of 
selectins is best illustrated  in two human  genetic diseases, 
leukocyte adhesion deficiency (LAD) I and II. Whereas LAD 
II is caused by a block in synthesis of fucosylated carbohy- 
drates (14),  LAD I is caused by mutations  in the gene en- 
coding the 32 (CD18) subunit used by the integrins LFA-1, 
Mac-l,  and p150,95  (15,  16).  In LAD I patients,  granulo- 
cytes are unable to migrate to and accumulate at sites of in- 
fection and inflammation (17, 18), but are able to adhere and 
roll on blood vessel  endothelium  in vivo (19). 
Although migration of circulating leukocytes from blood 
into surrounding tissues is a critical step of inflammation neces- 
sary for host defense, excessive  accumulation  of leukocytes 
can be harmful  and can lead to inflammatory disorders in- 
cluding vasculitis,  arthritis,  asthma, and ischemia-reperfusion 
injury. 
Septic shock is a systemic response to infection with high 
mortality (20).  70% of septic shocks in humans  are caused 
by gram-negative bacterial endotoxin and up to 30% are caused 
by gram-positive bacteria.  Staphylococcus  aureus  enterotoxin 
B (SEB) is a bacterial exotoxin from gram-positive bacteria 
that causes toxic shock in humans and in mice (21). The en- 
dogenous mediators TNF-o~ and IL-1, released in response 
to LPS and other products of gram-negative or-positive bac- 
teria have been identified as the principal  mediators  of the 
pathology in sepsis. The release of these endogenous medi- 
ators leads to a number of pathophysiological reactions, such 
as fever, leukopenia, thrombocytopenia, disseminated intravas- 
cular coagulation,  leukocyte infiltration  in various organs, 
and hemodynamic changes that ultimately may lead to lethal 
shock. It has been proposed that hepatic ischemia followed 
by a reperfusion syndrome is what causes the irreversible  liver 
damage in septic shock, but the mechanisms by which the 
release of inflammatory cytokines lead to this reperfusion in- 
jury are undetermined (22). In spite of the several adhesion- 
dependent phenomena that occur in septic shock, such as leu- 
kocyte activation and infiltration,  no evaluation of the role 
of adhesion  molecules in this process has  been performed. 
The concept of antiadhesion therapy has been validated in 
experimental animals by the demonstration that mAbs to inte- 
grins  and selectins inhibit leukocyte-mediated damage in a 
wide range of inflammatory disease models (23, 24). Anti- 
ICAM-1 antibodies inhibit leukocyte infiltration  and tissue 
injuries in several models of lung inflammatory disease (25, 
26), as well as kidney transplant rejection (27). Potential  short- 
comings of evaluating the in vivo function of a molecule with 
inhibitory mAbs are that mAbs can have additional effects 
such as immune-mediated damage or elimination of cells on 
which the target  antigen is expressed; mAbs bind to only 
a single epitope and may not block all adhesive interactions, 
especially for molecules such as ICAM-1 that have multiple 
integrin binding  sites;  and evaluation of long-term  effects, 
such as development,  is difficult. 
To date, most of our knowledge about ICAM-1 has been 
focused on its mechanisms of action in vitro, but the contri- 
butions of ICAM-1 in various inflammatory states in vivo, 
the significance in vivo of redundant  interactions  between 
leukocyte integrins and their ligands, as well as the separate 
functions of ICAM-1, -2, and -3, remain to be fully under- 
stood.  In this  study, we have generated ICAM-l-deficient 
mice by gene targeting  in embryonic stem (ES) cells  (28), 
and we have used these mutant  mice to study the specific 
role of ICAM-1  in  septic shock. 
Materials and Methods 
Gene Targeting in ES Cells.  The X phage clone 26 containing 
a portion of the ICAM-1 gene from the AKK mouse strain (29) 
was a kind gift of Dr. Adrienne Brian (La Jolla Cancer Research 
Foundation, LaJolla, CA). A 1.2-kb HindIII fragment containing 
exons 4 and 5 and an 8.0-kb HindIII fragment containing  exons 
6 and 7 were subcloned in pBlueScript (KS). To construct the tar- 
geting vector, a 1.7-kb EcoRI/HindIII fragment carrying a poly- 
adenylated neomycin resistance gene (neo/poly A +) under  the con- 
trol of the phosphoglycero kinase gene (PGK) promoter (a gift from 
Drs. En Li and RudolfJaenisch,  Massachusetts Institute  of Tech- 
nology, Cambridge, MA) was isolated from pKJ1 (30), and blunted 
with Klenow. This fragment  was inserted into  the NheI site in 
the fourth exon of the 1.2-kb HindlII fragment  of the ICAM-1 
gene. The resultant  2.9-kb HindIIl fragment containing  the neo" 
gene was then placed upstream  of the 8.0-kb HindlII fragment 
from the ICAM-1 gene in pBlueScript (KS). Finally, a blunted 2.7- 
kb EcoRI/HindlII fragment from pGEM7 (thymidine kinase [tk]) 
containing  the HSV tk gene under the control of the PGK pro- 
moter was subcloned in the above construct  cut with Notl and 
blunted with Klenow  (see Fig.  1). 
The J1 ES cell line, obtained from Dr. KudolfJaenisch (30), was 
routinely cultured  in DMEM supplemented with 15% FCS, 0.1 
mM nonessential amino acids (GIBCO BRL, Gaithersburg, MD), 
0.1 mM/~-ME, and antibiotics. J1 ES cells were grown on feeder 
layers of embryonic  fibroblasts  pretreated  with  20  #g/ml  of 
mitomycin C for 3-4 h.  103 U/ml of leukemia inhibitory  factor 
was included in the medium during selection and cloning. ES cells 
(5  x  107)  were transfected by electroporation (240 V and 500 #F) 
using 25 #g/ml of plasmid DNA linearized with PvuI, as previ- 
ously described (31). Transfected  cells were selected with G418 (200 
#g/ml of active form) and 0.2 #M FIAU (1-[2-deoxy, 2-fluoro-B- 
n-arabinofuranosyl]-5-iodouracil; Bristol-Myers Squibb Pharmaceu- 
tical Research, Seattle, WA) (31). Resistant colonies were picked 
from day 8-10 and expanded. DNA from each resistant colony was 
isolated and subjected to Southern blotting to identify clones that 
underwent homologous recombination. The mutant allele was de- 
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digested DNA. A total of 277 resistant clones were screened and 
one (clone 74) showed the expected DNA restriction pattern for 
homologous recombination in one allele. The DNA restriction pat- 
tern corresponding to the mutant allele was confirmed upon hy- 
bridization with a specific DNA fragment derived from the neo' 
gene. The neo' gene probe did not detect any additional band in 
the Southern blot, demonstrating no incidence of random integra- 
tion (data not shown). Furthermore, DNA digests from clone 74 
ES cells were analyzed with a probe 3' of the neo  r gene insertion 
(probe III), and the restriction patterns on Southern blotting were 
as predicted (data not  shown). 
Production of Chimeric and Homozygous Mutant Mice.  Clone 74 
ES cells carrying one mutated allele for the ICAM-1 gene were 
injected into C57BL/6 blastocysts to obtain chimeric mice (32). 
Chimeric mice were scored by agouti coat color in a black coat 
color background. Germline transmission  attributed to recombinant 
ES cells  was assessed by the  agouti coat color of the offspring 
resulting from the breeding of chimeric male mice with (C57BL/6 
x  DBA/2)F1  females.  DNA from tail biopsies from agouti off- 
spring was analyzed to confirm transmission of the mutation in 
the ICAM-1 locus. 6 of 13 chimeric male mice transmitted the dis- 
rupted gene to their progeny. Mice heterozygous for the ICAM-1 
gene disruption were intercrossed to produce homozygous mutant 
mice. 
Hematology.  Mice  were  bled  from  retro-obital  plexus  with 
heparinized capillaries. Whole blood was diluted 1:10 in 2% acetic 
acid and total white blood cell counts determined on a hematocytom- 
eter. Blood smears were prepared and stained with LeukoStat (Sigma 
Chemical Co., St. Louis, MO) to count leukocyte differentials.  The 
absolute numbers of each leukocyte population were calculated by 
multiplying the total white blood cell counts by differentials. 
Isolation and Stimulation of Thymocytes and Splenocytes.  Thymo- 
cytes and splenocytes from wild-type and mutant mice were re- 
suspended in RPMI medium, erythrocytes were lysed with 0.15 
M NH4C1,  1.0 mM KHCO3, and cell debris was removed by three 
washes.  Thymocyte and  splenocyte responses  to  mitogen were 
performed as previously described (33). Splenocytes or thymocytes 
(5  x  10  s) were cultured in complete RPMI medium supplement- 
ed with 10%  FCS in the presence of 15 #g/ml of LPS and/or 4 
/zg/ml of Con A  for 3 d. 
Antibodies and Flow Cytometry.  Cell suspensions from thymus, 
spleen, lymph nodes, and bone marrow of 8-12-wk-old animals 
were prepared free from red blood cells following standard proce- 
dures. For two- and three-color flow cytometry, cells were stained 
with antibodies directly conjugated with fluorochrome: anti-CD4 
(H129.19),  anti-CD8  (53-6.7),  and  anti-CD3  (YCD3-1)  from 
GIBCO BILL; anti-B220 (RA3-6B2),  anti-ICAM-1 (3E2),  anti- 
IgM  (DS-1),  and  anti-Gr-1  (RB6-8C5)  from PharMingen  (San 
Diego, CA). The cells were incubated at 4~  for 30 min, washed 
three times, and fixed in PBS/1% formaldehyde before analysis on 
a FACScan  |  instrument (Becton Dickinson & Co., Mountain View, 
CA).  Samples for one-color analysis were stained with  anti-vas- 
cular cell adhesion molecule 1 (548), anti-LFA-1 (M17/4) (34), anti- 
Mac-1 (M1/70) (35) and anti-ICAM-2 (IC2-3C4; Xu, H., and T. 
Springer,  manuscript in preparation). FITC-labeled rat anti-mouse 
fc chain antibody (MARK) from Amac, Inc. (Westbrook, ME) was 
used as the secondary antibody. 
Immunohistology.  Animals were killed by CO2 asphyxiation, 
organs were immediately removed, frozen in  dry ice/2-methyl- 
pentane, and stored at  -70~  Frozen sections were prepared ac- 
cording to standard procedures. The frozen sections were stained 
with hamster anti-mouse ICAM-1 mAb 3E2, washed to remove 
unbound antibodies, and stained with biotinylated goat anti-ham- 
ster IgG followed by avidin-biotin-peroxidase complexes using a 
Vectastain  Elite ABC kit (Vector Laboratories, Inc., Burlingame, 
CA) according to the manufacturer's instructions. The sections were 
counterstained with methyl green. 
Skin Contact Sensitivity Reaction.  Normal BDF1 mice and ho- 
mozygous mutant mice at 8-12 wk of age were sensitized with 
100/zl of 0.2%  2,4-dinitro-l-fluorobenzene  (DNFB) in 3:1  ace- 
tone/olive oil, applied evenly on a shaved area of skin on the ab- 
domen.  On day 5,  sensitized mice were challenged by applying 
0.2% DNFB to the right ear (10 #1 on the inner side and 10/~1 
on the outer side of the ear) (36). The thickness of the central por- 
tion of each lobe was measured 24 h after challenge using an en- 
gineer's micrometer (The Dyer Company, Lancaster,  PA). 
Septic Shock,  LPS from Escherichia coli  0127:B7, SEB, and D-ga- 
lactosamine (n-Gal) were purchased from Sigma Chemical Co. In 
septic shock experiments, age- and body weight-matched control 
(BDF1 strain,  The Jackson Laboratory, Bar Harbor, ME, and wild- 
type littermates) and ICAM-l-deficient mice were injected intra- 
peritoneally with 40 mg/kg LPS or with a mixture of D-Gal (20 
mg/mouse) and the amounts of LPS or SEB indicated in the results 
section. All animals were cared for by a full-time veterinary staff 
and monitored daily for signs of morbidity. Two wild-type mice 
exhibiting painful distress (convulsions) were killed by cervical dis- 
location, and were excluded from the experiments. Invasive proce- 
dures were carried out under anesthesia with metafane (Pitman- 
Moore, Inc., Mundelein,  IL). 
Cytokine Measurement.  The systemic release of cytokines after 
toxin challenge was determined by ELISA. Blood was taken at in- 
dicated time points after treatment and cytokine concentrations 
were measured in duplicate. Sera from two or three different animals 
was pooled within each group to reduce the number of samples. 
Two pools from each experimental and control group were mea- 
sured.  Serial dilutions  of serum samples were assayed by ELISA 
for TNF-ot, IL-6, and IL-lot (Endogen, Inc., Boston, MA) as recom- 
mended by the supplier.  Absorbance values read at 450 nm were 
converted to concentrations (picograms per milliliter) in the serum 
by comparison with the respective standard curve. 
Histology.  Tissues were fixed in 10% formaldehyde, sectioned, 
and stained with hematoxylin and eosin. The pathohistology of 
the livers of D-Gal-sensitized mice challenged either with LPS or 
SEB was studied 10--12 h after treatment in sections of at least three 
different animals per group. The chloroacetylesterase histochem- 
ical procedure was used to aid in the visualization of neutrophils. 
For the evaluation of neutrophil infiltration in the high-dose LPS 
model, neutrophils in liver sections in five mutant (-/-)  and four 
wild-type  (+/+)  mice were  quantitated  by counting  the  total 
number of neutrophils, as well as the number of small (two to five) 
and large (over five) neutrophil clusters in eight high-power fields 
(at a magnification of 40; total area 0.5 mm2), which were selected 
randomly at a low-power magnification of 4 at which neutrophils 
are not visible. 
Results 
Disruption of the ICAM-1  Gene and Generation of lCAM- 
1-deficient Mice.  The mouse ICAM- 1 gene consists of seven 
exons  (29,  37).  Exon  I  encodes  the  5' untranslated  region 
and signal peptide, exons 2-6 encode the five Ig-like domains, 
and exon 7 encodes the transmembrane and the cytoplasmic 
domains. To disrupt the ICAM-1 gene by homologous recom- 
bination,  a  replacement  vector was  made  (28)  with  a  neo' 
97  Xu et al. cassette inserted  in exon 4  (Fig.  1 A).  The targeting  con- 
struct also contained the tk gene to allow negative selection 
in  screening  for homologous  recombination  (28,  31). 
ES cells of the J1 line were transfected with the targeting 
vector and  selected for resistance  to G418 and  FIAU  (30). 
Southern blots of DNA from resistant colonies showed ho- 
mologous  recombination  in  ES cell clone 74.  The fidelity 
of homologous recombination in clone 74 was confirmed with 
probes on both sides of the replacement vector integration 
site. ES cells from clone 74 were expanded and microinjected 
into C57BL/6 blastocysts to make chimeric mice. Six inde- 
pendent fertile chimeras transmitted the mutant allele to the 
offspring.  Two of these lines were propagated and used for 
further  analysis.  A  representative Southern  blot  of a  litter 
resulting from intercross between mice heterozygous for the 
ICAM-1 mutation is shown in Fig. 1 B. Three of the offspring 
were heterozygotes and showed both a 3.8-kb BamHI DNA 
fragment from the wild-type allele and a 2.7-kb BamHI band 
corresponding  to  the  mutant  allele.  Two  of the  offspring 
showed only the band from the mutant allele and, therefore, 
were homozygous for ICAM-1 disruption. The predicted fre- 
quency of homozygous mutant  animals  was obtained both 
inside and outside a specific pathogen-flee animal facility. Mice 
homozygous for ICAM-1 gene disruption did not show any 
gross  abnormality  in  development  or fertility. 
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Figure 2. 
ICAM-1  ICAM-2  LFA-I 
LOG  FLUORESCENCE INTENSITY 
Expression  of  adhesion  molecules  on mitogen-stimulated  lyre- 
phoblasts. Con A-stimulated thymocytes  (A) or Con A and LPS-stimuhted 
spleen cells (B) from wild-type (thin line) or ICAM-l-deficient (thick  line) 
mice were stained with mAbs to the indicated adhesion molecules  or con- 
trol ascites and subjected to flow cytometry. 
The Lack of  lCAM-I in Homozygous Mutant Mice Does Not 
Affect Lymphoid Development but Results in Reduced Antigen- 
specific Immune Responses.  ICAM-1  expression is very low 
on resting lymphocytes but is greatly increased upon stimu- 
lation by mitogens (38). Therefore, thymocytes and spleno- 
cytes isolated  from normal  and  homozygous mutant  mice 
were treated for 72 h  with ConA  and with a combination 
of ConA  and LPS,  respectively, before being examined for 
expression  of ICAM-1  by  immunofluorescence  and  flow 
cytometry  (Fig.  2).  Mitogen-stimulated  thymocytes  and 
splenocytes from  wild-type  control  mice showed  high  ex- 
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Figure  1.  Design  of the replacement  vector  and South- 
ern blots showing mutant allele segregation in a repre- 
sentative litter. (,t) Strategy for homologous recombina- 
tion.  (a) The replacement vector contains a PGK-neo" 
gene cassette inserted in the exon 4. The neo"  gene in- 
sertion was flanked by 0.7- and 8.0-kb DNA from the 
ICAM-1 locus. (b)  Restriction map  of the  wild-type 
ICAM-1 locus. (c) Restriction  map of the mutated  ICAM-1 
allele after homologous recombination. The locations of 
probe I (a BamHI/Hindlll genomic DNA fragment), 
probe II (an NheI cDNA fragment) and probe III (an 
NcoI/SalI genomic fragment) are indicated. Exons are 
shown in black and are numbered. Restriction sites listed 
are: (B) BamHI; (E) EcoRl; and (//) HindIIl. (B) Southern 
blots of  tail DNA isolated  from a litter of  seven  mice  from 
a heterozygous intercross. Tail DNA was digested with 
restriction enzyme BamHI, electrophoresed,  blotted, and 
hybridized with probe I. The fragments detected by the 
probe from the normal and mutated allele are indicated. 
(Tbp) The genotypes of individual mice. Figure  3.  ICAM-1 expression in 
lung. Frozen sections of lungs from 
wild-type (A) and ICAM-l-deficient 
(B) mice  were  stained  with  anti-ICAM-1 
mAb and peroxidase  and then  counter- 
stained with methyl green. ICAM-1 
expression appears as black staining 
in the light gray background. Black 
spots (B) are due to background  perox- 
idase activity. Bar, 200/~m. 
pression of ICAM-1 whereas cells from the homozygous mu- 
tant mice showed no expression  of ICAM-1. Wild-type and 
mutant cells expressed equivalent levels of LFA-1 and ICAM-2. 
ICAM-1 was also absent on primary keratinocytes isolated 
from mutant mice  as  shown by flow cytometry, whereas 
normal keratinocytes expressed low levels of ICAM-1 (data 
not shown). 
ICAM-1 has been shown previously to be expressed  on 
a wide variety of nonhematopoeitic cells (4,  6).  Immuno- 
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histochemical staining of frozen sections of wild-type mice 
showed diffuse ICAM-1 positive staining in lung on alveolar 
epithelial cells, in blood vessel endothelium, and in certain 
interstitial areas (Fig.  3).  In the thymus, ICAM-1 was ex- 
pressed on cortical and medullary thymocytes and on thymic 
epithelial cells (data not shown). By contrast, mutant mice 
were completely negative for ICAM-1. 
The distribution of ICAM-1 on thymic epithelial cells in 
fetal and adult thymus and on germinal center dendritic cells has led to the hypothesis that ICAM-1 might play a role in 
thymocyte  maturation  and  in  the  formation  of germinal 
centers.  However, no detectable differences in the absolute 
numbers of major T and B cell subsets were observed in the 
thymus,  spleen,  and lymph  nodes between wild-type and 
ICAM-l-deficient mice (data not shown). The only detect- 
able cellular difference between ICAM-l-deficient and wild- 
type mice was a significant elevation in circulating  neutro- 
phils  and lymphocytes (see below). 
To investigate whether there was any defect in lympho- 
cyte function,  we  performed  mixed  lymphocyte reaction 
(MLR) assays to measure T cell proliferation in response to 
allogeneic cells. These experiments showed that lymphocytes 
from ICAM-l-deficient mice are not hindered as responders, 
but are diminished in their ability to stimulate an allogeneic 
response (data not  shown). 
Administration  of antibodies against LFA-1 and ICAM-1 
in mice partially  inhibits  the delayed-type hypersensitivity 
(DTH) reaction induced by DNFB (39). Anti-LFA-1 inhibits 
the reaction more substantially than  anti-ICAM-1.  In this 
model of in vivo T cell responses to specific antigen, ICAM- 
1-deficient mice showed a significant reduction in ear swell- 
ing  as the hapten-specific  reaction  was reduced by "~50% 
(Table 1). 
ICAM-l-deficient Mice Are Resistant to the Lethal Effect of 
High Doses of  Endotoxin but Do Not Show Decreased Production 
of TNF-cr and IL-1.  Lethal endotoxin  shock was induced 
by intraperitoneal injection of high doses of LPS (40 mg/kg) 
in mice at 8-14 wk of age. Normal mice demonstrated a series 
of responses including  shivering,  a sign of fever,  lethargy, 
watery eyes due to enhanced vasopermeability, and ultimately, 
death.  Only 21% of the wild-type mice survived (4 of 19) 
and the deaths occurred 24-48 h  after receiving LPS (Fig. 
4). Similar symptoms of endotoxin shock were observed in 
ICAM-l-deficient mice, but the animals were less lethargic. 
Most importantly,  the vast majority  (22 of 23  animals  in 
experiment 1) of ICAM-l-deficient mice survived LPS shock 
(Fig. 4). It thus appears that cell-cell interaction via ICAM-1 
is an important  mechanism  in the sequence of events that 
lead to lethality  during  endotoxin  shock. 
Administration  of LPS to mice induces production  and 
secretion,  largely by macrophages,  of the proinflammatory 
cytokines TNF-ot, IL-1, and IL-6, which are released sequen- 
Table  1.  Reduced Contact Sensitivity Reaction in 
ICAM-I-deficient  Mice 
Ear thickness  (Mean #m  +  SD) 
Unchallenged  Challenged  Increase  in 
Genotype  ear  ear  ear thickness* 
+/+  (n  =  5)  220  +  8.9  442  _+ 36.6  222  +  31.9 
-/-  (n  =  6)  228  _+  13.4  338  _+ 42.2  110  _+ 50.3 
* p <0.005 (by Student's t test). 
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Figure 4.  Survival  of mice treated with a lethal dose  of  LPS. Mice  were 
given 40 mg/kg ofLPS i.p. on day 0. Survival data are shown from three 
independent experiments, with age- and body weight-matched mice, with 
19 wild-type (+/+, open square) and 23 mutant (-/-, filled circle), housed 
both inside and outside a specific pathogen-free facility, p value for the 
difference in the survival rate was <0.005, tested by X  2. 
tially into the circulation (40). The peak concentrations for 
these cytokines in the serum are detected between I  and 4 h 
after LPS administration,  reaching a plateau level after this 
period. To examine whether ICAM-1 mutant mice have al- 
tered serum levels of inflammatory cytokines, we have fol- 
lowed the kinetics of systemic TNF-ot, IL-1, and IL-6 release 
in ICAM-1 mutant and wild-type mice after challenge with 
a lethal  dose of LPS.  No  significant  differences in  the cir- 
culating levels of TNF-ot or IL-1 were observed between mu- 
tant and wild-type mice (Fig.  5 A). Similar results were ob- 
tained  for IL-6  serum levels  (data not  shown). 
Leukocyte counts were monitored during LPS shock (Fig. 
5 B). Baseline white blood cell counts were severalfold higher 
in ICAM-l-deficient mice. Neutrophils were two to six and 
lymphocytes  were  two  to  three  times  higher  in  ICAM- 
1-deficient mice, even though there was no sign of infection 
and mice were specific  pathogen-free.  2 h  after LPS injec- 
tion, there was a drastic decline of circulating neutrophil and 
lymphocyte counts in both wild-type and ICAM-l-deficient 
mice. The circulating neutrophil counts in ICAM-l-deficient 
mice dropped to a similar level to those of wild-type mice 
at 2 h,  but rose back to an elevated level at 6 h  after LPS 
treatment  (Fig.  5 B).  By contrast,  the LPS-induced lym- 
phopenia was sustained in both ICAM-1-deficient and wild- 
type mice (Fig.  5 B). 
Leukocyte accumulation  and infiltration  were examined 
histologically in organs from mice killed at 2 and 24 h after 
LPS treatment.  The most significant histopathologic differ- 
ence between wild-type and deficient mice was in the liver 
24 h after LPS treatment  (Table 2 and Fig. 6). The liver of 
each LPS-treated wild-type mouse showed diffuse infiltration 
with leukocytes, predominantly neutrophils.  Neutrophils were 
present as single or rows of cells within hepatic sinusoids, 
or as clusters of neutrophils within the hepatic cords, often 
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Figure  5.  Systemic release ofcy- 
tokines  (A) and  peripheral  blood 
neutrophil and lymphocyte counts 
(B) before and after administration 
of high doses of LPS. (.4) Wild-type 
or ICAM-1 mutant mice (four  to 
six per group) were bled from the 
retro-obital plexus with heparinized 
capillaries at indicated times after in- 
jection of LPS. At different  time 
points,  different groups  of animals 
were used. Within each group, two 
pools  of sera from  two  to  three 
animals  each  were  measured  by 
ELISA in duplicate. One represen- 
tative  experiment  out  of two  is 
shown.  (B) Mice (four  to six per 
group)  were bled from the retro- 
obital plexus with hepadnized capil- 
laries before or at 2, 6, and 24 h after 
intraperitoneal  injection  of  LPS. 
Total and differential white blood 
cell  counts  from individual  mice 
were determined,  and the absolute 
numbers  of neutrophils  (A)  and 
lymphocytes  (B)  were  calculated 
(shown  as the mean  ___  SD). 
Table  2.  Quantitation of Neutrophils in Liver Sections Obtained 24 h after Induction of High-dose LPS Septic Shock 
Number of neutrophils  (per  0.5  mm2) * 
Clusters* 
Genotype  2-5  >5  Totals 
+/+ 
+/+ 
+/+ 
+/+ 
Mean  •  SD  25.5 
-/- 
--//_ 
Mean  +  SD  2.6 
23  14  165 
27  8  163 
29  14  187 
23  14  169 
•  2.6  12.5  •  2.6  171  •  9.5 
2  0  64 
1  0  54 
4  1  63 
4  4  104 
2  1  61 
•  1.3 II  1.2  •  1.61  69.2  •  19.8"* 
* Fields were selected at low-power (4 x ) magnification  to ensure  random selection  and quantitated  at 40X magnification. 
* Number of clusters  per 0.5  mm  2 containing two to five or more than five cells per cluster. 
S Total neutrophils within clusters  plus  those present  as single  cells. 
IIp  =  0.0008  (by Student's t test). 
Ip  =  0.0025  (by  Student's t test). 
**p  =  0.0001  (by Student's  t test). 
101  Xu et al. Figure  6.  Representative  liver 
sections from mice during  high- 
dose endotoxin shock. Livers  from 
wild-type (-4) and  ICAM-l-defi- 
cient (B) mice that were killed 24 h 
after  intraperitoneal injection of 
LPS were fixed in  10% formalin, 
sectioned, and stained  with chloro- 
acetylesterase to visualize neutro- 
phils. The arrows and arrowheads 
indicate neutrophils, which are pre- 
sent as single  cells  (small arrowheads), 
as rows of  cells within the sinusoids 
(/arge arrowhead),  or  as  small or 
large cellular clusters within  the 
hepatic parenchyma (arrow).  Bar, 
100/zm. 
obscuring hepatic cells. The majority of clusters were made 
up of two to five neutrophil profiles, but larger accumula- 
tions of up  to  10 nuclei and occasional aggregates  of more 
than  10  nuclei were present.  Although  the  severity of the 
infiltrate varied in areas of the liver among individual animals, 
neutrophil clusters were present in virtually all fields of all 
four wild-type livers examined at 24 h  after LPS injection. 
In  contrast,  the  livers  of ICAM-l-deficient  mice  showed 
significantly fewer clusters and aggregates (Table 2), and areas 
of  the  liver  with  clusters  were  scattered  and  small  In- 
trasinusoidal neutrophils, however, were present and in many 
areas appeared greater in number over wild-type liver, reflecting 
the marked increase in peripheral neutrophil counts in  the 
ICAM-1  mutant  mice (Fig.  5 B).  We could not unequivo- 
cally document  differences in neutrophil  infiltration in the 
lung and spleen sections.  There was little neutrophil influx 
in the kidney and heart in either group.  It is interesting to 
note that the livers of mice of both groups treated with LPS 
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n-Gal  LPS  SEB  Lethality 
Genotype  (mg, i.p.)  (/~g, i.p.)  (/~g, i.v.)  (death/total) 
+  /  +  20  10  -  3/3 
+  /  +  20  10  -  4/5 
+  /  +  20  50  -  3/3 
-  /  -  20  10  -  4/4 
-  /  -  20  10  -  2/4 
-  /  -  20  50  -  6/6 
+  /  +  20  -  50  4/4 
+  /  +  20  -  50  3/3 
+  /  +  20  -  50  4/5 
-  /  -  20  -  50  1/6 
-  /  -  20  -  50  1/5 
-  /  -  20  -  5O  0/4 
+  /  +  20  -  -  0/4 
-  /  -  20  -  -  0/6 
+  /  +  -  -  50  0/4 
-  /  -  -  -  50  0/6 
+  /  +  -  10  -  0/7 
/  -  10  -  0/6 
+  /  +  -  40  mg/kg  -  9/10 
/  -  40  mg/kg  -  1/12 
for  2  h  had  many neutrophils  in  the  sinusoids  with  no 
significant differences in numbers. 
D-Gal-sensitized ICAM-1-deficient Mice Are Resistant to the 
Lethal Effect of Low Doses of Exotoxin (SEB) but Not to Low 
Doses ofEndotoxin (LPS).  Although mice are more resistant 
than humans to the pathogenic effects of bacterial toxins, septic 
shock can be induced by low doses of endotoxin or exotoxin 
after sensitization with D-Gal. D-Gal sensitizes  mice to the 
lethal effect of toxins by lowering the threshold of hepato- 
cyte susceptibility to the toxic products of macrophages and/or 
T  cells (41),  Mice sensitized with D-Gal and challenged at 
the same time with a low dose of LPS (10 or 50/xg) or SEB 
(50/~g)  die with liver failure (41,  42). 
Groups of mutant or wild-type mice received a dose of 
20  mg i.p.  of D-Gal, followed immediately by the injection 
of a low dose of LPS or SEB (Table 3). Animals receiving 
PBS, D-Gal, SEB, or LPS alone served as controls. In our study, 
D-Gal sensitization and challenge with SEB sufficed to cause 
death in virtually all wild-type mice in three independent 
experiments (Table 3).  It is striking that SEB challenge of 
D-Gal-sensitized ICAM-1 mutant mice did not result in death 
(87% survival; Table 3). In contrast, sensitized ICAM-I-de- 
ficient mice showed the same mortality rate as the wild-type 
group when challenged with LPS. Thus, ICAM-1 deficiency 
protected o-Gal-sensitized mice challenged with SEB but not 
with LPS. In accordance with published data (41, 42), con- 
trol wild-type or mutant unsensitized animals injected with 
SEB (up to 100/~g) or LPS (up to 50/xg) showed only mar- 
ginal signs of disease such as immobility and rough fur, but 
not lethality. 
Histopathological analysis was performed on three livers 
taken from animals 10 h after administration of SEB or LPS 
and D-Gal (Fig.  7).  Sections taken from the liver tissue of 
wild-type or ICAM-1 mutant mice coinjected with D-Gal 
and LPS showed massive, widespread hepatic cell necrosis and 
extensive parenchymal hemorrhage. The hepatic cells that were 
not necrotic showed cytoplasm vacuolization, "nuclear frag- 
mentation" karyolysis,  and membrane ruptures  (Fig.  7,  C 
and D). However, the liver sections of D-Gal-sensitized mice 
injected with SEB showed significant differences between wild- 
type and mutant mice. Thus, in the wild-type animals there 
were numerous apoptotic cells singly (single cell necrosis) 
or in small clusters throughout the hepatic parenchyma, as 
well as areas of patchy necrosis and neutrophil infiltration 
with minimal or no hemorrhage (Fig. 7 A). In contrast, there 
were appreciably fewer apoptotic cells and no areas of necrosis 
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7 B). The liver of one out of four mice from the latter group 
showed neutrophil clusters such as those described above. 
The basic difference between these two D-Gal septic models 
is that macrophages are the main mediators of the reaction 
triggered by endotoxin (43), while the lethal shock triggered 
by SEB is mediated by T  cells (42).  Nevertheless,  TNF-a, 
presumably produced by these target cells, is viewed as the 
principal mediator in both types of shock (20,  42, 44).  We 
studied the kinetics of systemic TNF-a and IL-1 release up 
to 5 h after coinjection of SEB or LPS with D-Gal in wild- 
type and ICAM-l-deficient mice. As shown in Fig. 8, marked 
differences  in TNF and IL-1 levels were observed between 
D-Gal-sensitized ICAM-1-deficient and wild-type mice chal- 
lenged with SEB. Thus, TNF-a and IL-1 levels 90 min after 
treatment were reduced by >50% in ICAM-l-deficient mice 
when compared with wild-type controls. More importantly, 
lower systemic levels of these two cytokines were sustained 
in the ICAM-1 mutant for up to 8 h  after treatment (data 
not shown). This difference was specially marked for IL-1, 
which after 3 h was virtually undetectable in the serum of 
exotoxin-treated ICAM-l-deficient mice. In contrast, only 
small differences were detected in the systemic levels of TNF-c~ 
or IL-1 during the first 3 h, and no differences were observed 
3  h  after LPS and D-Gal treatment. 
Discussion 
Our study shows that ICAM-1 is not essential for devel- 
opment and leukocyte maturation, plays an important role 
in antigen-specific immune functions, and is critical for mor- 
tality in septic shock. The mutation that we have introduced 
inactivates  the ICAM-1 gene, creating mice that completely 
lack ICAM-1 on leukocytes and on endothelial and epithelial 
cells  in  various  tissues.  The  phenotype  of these  ICAM- 
1-deficient mice can be exclusively attributed to the absence 
oflCAM-1. An alternative ligand for LFA-1 that is constitu- 
tively expressed on endothelial cells and lymphocytes, ICAM-2, 
remains present. 
Defective Immune Responses and Leuleocytosis in ICAM-1- 
deficient Mice.  The  increase  in  circulating neutrophils  in 
Figure  7.  Representative  liver  sections  from  D-Gal-sensitized  mice  challenged  with LPS or SEB. Livers  from  wild-type  (A and C) and ICAM-l-deficient 
(B and D) mice that were killed 12 h after coinjection of D-Gal with SEB (A and B) or D-Gal with LPS (C and D) were fixed in 10% formalin, 
sectioned, and stained  with hematoxylin-eosin.  Note that after  D-Gal/SEB treatment,  areas of hepatic  cell necrosis (large  arrowheads)  appear in wild-type 
livers (A), and are absent in ICAM-l-deficient  livers (B). In addition, fewer  apoptotic (single  cell necrosis) cells (small  arrowheads)  are observed in the 
mutant. In contrast, after D-Gal/LPS treatment, extensive  necrosis and hemorrhage  are present in both wild-type  (C) and mutant mice (D). 
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Figure  8.  Kinetics of systemic cytokine 
release in D-Gal-sensitized mice after chal- 
lenge  of  LPS  or  SEB. Wild-type  and 
ICAM-l-deficient mice (four  to  six per 
group)  were bled  from  the  retro-obital 
plexus with heparinized capillaries at indi- 
cated times after coinjection  of D-Gal and 
LPS or SEB. The bleeding was performed 
under anesthesia  and after  the procedure 
the mice were  killed.  At  different  time 
points,  different  groups  of animals were 
used.  Within  each  group,  two pools  of 
sera from two to three  animals each was 
measured by ELISA in duplicate. One rep- 
resentative  experiment  out  of  three  is 
shown￿9 
ICAM-l-deficient mice resembles leukocytosis in LAD I pa- 
tients that are deficient in/32 integrins. However, ICAM-1 
deficiency results in a modest elevation of circulating neutro- 
phil counts (two to six times normal) compared with the 
5-20-fold elevation of neutrophil counts in LAD I patients 
(15, 16). This may be related to the partial as compared to 
the complete absence of interactions dependent on the/32 
leukocyte integrins, in ICAM-1 deficiency and LAD I, respec- 
tively. Similarly, there is a relatively low elevation (2.4-fold) 
of circulating neutrophils in P-selectin-deficient mice (45) 
compared with LAD II, in which a primary defect in fucose 
synthesis results in a lack of carbohydrate ligands for both 
P- and E-selectin (14, 46).  The degree of peripheral blood 
granulocytosis may reflect the severity of the impairment of 
leukocyte adherence and extravasation. 
Previous studies using thymic organ culture showed that 
the presence of a blocking mAb to ICAM-1 affected T cell 
maturation in vitro (47). In this system, the effect of blocking 
ICAM-1 during T cell differentiation resulted in the accumu- 
lation of CD4-CD8-  thymocytes and a delay in the gener- 
ation of CD4+CD8 + cells. However, our characterization 
of ICAM-l-deficient mice showed normal distribution of 
major thymocyte subsets and demonstrates that ICAM-1 is 
not absolutely required for thymocyte development in vivo. 
This study reveals that ICAM-1 is necessary to achieve op- 
timal antigen-specific immune functions. MLR experiments 
show the requirement for ICAM-1 on the APCs to reach 
full T cell activation, reinforcing the importance of adhesion 
between T cells and APCs. These fndings are in agreement 
with previous studies that have demonstrated  by mAb blocking 
and gene transfection that ICAM-1 expression on APCs lowers 
the concentration of specific antigen required to stimulate 
T cell responses (48-52), and that LFA-1 on T cells contributes 
to antigen-specific  responses  (48,  53-55). 
We have also shown that hapten-induced contact sensitivity 
was reduced in ICAM-l-deficient mice. Previously, antibodies 
to CDllb, LFA-1, and ICAM-1 have been shown to inhibit 
different routine models of DTH (40, 56). Our study, which 
shows a 50% reduction of contact sensitivity in ICAM-I-de- 
ficient  mice, parallels the amount of inhibition seen with 
anti-ICAM-1 mAb. The residual  response may be due to 
the presence of another adhesion ligand for LFA-1, namely 
ICAM-2. An independent study on ICAM-l-deficient mice 
(57) showed reduced antigen-specific  immune responses in- 
cluding MLR and DTH, and leukocytosis. These results are 
in good agreement with those in our study. 
Role of lCAM-1  in Septic Shock.  The major finding of 
this study is that ICAM-1 deficiency renders mice resistant 
to high-dose endotoxin lethal shock. The mechanism under- 
lying this protection appears to be distal to the event trig- 
gering cytokine production, since TNF-ol and IL-1 levels were 
similar in wild-type and ICAM-l-deficient mice. Macrophages 
appear to be essential in mediating endotoxin reactions, since 
adoptive transfer of endotoxin-sensitive macrophages renders 
previous endotoxin-resistant  mice sensitive to endotoxin (43). 
Further, it has been established that the macrophage product 
TNF-o~ is central in causing endotoxin lethality (44). This 
cytokine, in addition to IL-1, plays a central role in the in- 
creased leukocyte adhesion, aggregation, activation, as well 
as in the diffuse intravascular  coagulation that characterize 
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LPS or TNF-oe produce an early and pronounced decline in 
peripheral blood neutrophil counts, which is largely accounted 
for by-margination and aggregation of neutrophils in the 
microvasculature. During the process of neutrophil activa- 
tion and adherence to endothelium, and accumulation in tissue, 
neutrophils may release free oxygen metabolites and various 
proteases that damage endothelial cells and tissues (59, 61, 
62). Furthermore, leukocyte adhesion and aggregation, as well 
as intravascular coagulation and thrombosis,  lead to occlu- 
sion of microvasculature and local ischemia. Neutrophil deple- 
tion protects mice from endotoxin shock (61). Our findings 
are all the more impressive because ICAM-l-deficient mice 
have elevated numbers of circulating neutrophils. 
ICAM-l-deficient mice clearly showed responses to high 
doses of LPS, including shivering, lethargy, and watery eyes. 
Blood neutrophil counts of ICAM-1-deficient mice declined 
as rapidly as those of normal mice within the first 2 h after 
administration of LPS. Furthermore, normal and ICAM- 
1-deficient livers had approximately similar numbers of neu- 
trophils  at 2 h, as judged histologically. However, at 24 h, 
there were distinctly fewer neutrophils infiltrating the liver 
in all ICAM- 1-deficient mice, compared with wild-type con- 
trols. These observations suggest that ICAM-1 deficiency  does 
not affect the initial sequestration of neutrophils that causes 
the immediate decline in circulating neutrophils. This seques- 
tration, which is especially prominent in the lung, results 
from increased viscosity of activated neutrophils,  which pre- 
vents the deformation required for passage through capillaries 
(63, 64). The significant decrease in neutrophil infiltration 
in the liver at 24 h can be interpreted as reflecting deficient 
adhesion strengthening and transmigration, normally medi- 
ated by ICAM-1 binding to Mac-1 and LFA-1. This is sup- 
ported by studies of Sligh et al. (57) demonstrating that, in 
ICAM-l-deficient mice, neutrophil accumulation in the peri- 
toneal cavity in response to sterile inflammatory stimuli was 
diminished.  We propose that the ICAM-1 protection in this 
model operates via abrogation or diminution of  leukocyte--en- 
dothelial interactions, lowering emigration of  leukocytes into 
tissues as well as the release of leukocyte proteases and toxic 
metabolites that cause tissue damage or vasoactive mediators 
that cause ischemia. This mechanism of protection is sup- 
ported by our own results showing high TNF-ot serum levels 
in protected ICAM-l-deficient mice, as well as by the results 
reported by Rothe et al. (65), who showed that TNF recep- 
tor-deficient mice are resistant to a low-dose LPS toxic shock 
(see below), but are highly susceptible to a high-dose LPS 
toxic shock. Another potential mechanism of  protection would 
be decreased  intravascular  coagulation, perhaps associated  with 
a role of ICAM-1 as fibrinogen receptor (66). 
Septic shock can be induced by both gram-negative and 
-positive bacteria, although the latter are responsible for only 
25% of the reported cases. Bacterial endotoxin is recognized 
as the major factor in the pathogenesis of  gram-negative septic 
shock (20), whereas exotoxins from gram-positive  bacteria 
cause toxic shock in humans and in mice (67). Exotoxins ex- 
hibit properties of superantigens thereby stimulating in vivo 
and in vitro massive T cell proliferation.  The basic difference 
in the mechanism of action in vivo between endotoxins and 
exotoxin is that the endotoxin reactions are mediated by mac- 
rophages whereas the lethal shock triggered by the superan- 
tigen (i.e., exotoxin SEB) is mediated by SEB-reactive  T cells. 
Because mice are relatively resistant  to bacterial toxins, 
the effects of a high dose of toxin in a murine model might 
resemble a substantially lower dose in human shock (42). 
To study the role of ICAM-1 in low-dose toxic shock models, 
we took advantage of the heightened sensitivity to bacteri- 
al toxins of mice treated with D-Gal to impair liver meta- 
bolism  (41). 
In contrast to the treatment with high doses of LPS in 
unsensitized mice, D-Gal-sensitized ICAM-l-deficient mice 
are not resistant to low doses of LPS. After D-Gal treatment, 
hepatocytes are severalfold  more sensitive to endogenous medi- 
ators (TNF and IL-1) released after macrophage activation 
by LPS or by SEB-activated T cells (41). As a consequence, 
reperfusion injury and extensive hepatocyte necrosis occurs, 
followed by death (22, 68). The importance of cytokine- 
rather than leukocyte-dependent  damage in this  model is 
confirmed by our finding that cytokine production and le- 
thality in ICAM-l-deficient mice are unaffected. This view 
is further supported by the complementary phenotype ob- 
served in TNF receptor-deficient mice (65). However, in the 
D-Gal/SEB-treated  group, the ICAM-1 deficiency results in 
significantly lower levels of TNF, as well as in maintained 
decreased levels of IL-1, which is virtually absent 3 h after 
treatment. Since in mice the lethal effect of TNF-ol is po- 
tentiated by IL-1 (40), and fatal outcome in human septic 
shock is  associated with high levels of not only TNF-o4 
but also IL-1 (67, 69), the markedly decreased levels oflL-1 
in  SEB/D-Gal-treated  ICAM-l-deficient mice  might  be 
responsible, together with the decrease in TNF levels, for 
the resistance to lethality.  The reduced levels of TNF and 
IL-1 probably reflect directly, or as a secondary event, dimin- 
ished T cell responses to SEB in vivo in ICAM-l-deficient 
mice. In fact, the response of Vfl8 T cells (SEB reactive) to 
SEB is diminished from 40 to 60% in ICAM-l-deficient mice 
both in vivo and in vitro (Gonzalo,  J. A., unpublished results). 
In addition, other T cell cytokines such as IFN-% mediators 
in the hypersensitivity to toxins, are likely to be reduced in 
ICAM-l-deficient mice. 
Thus, macrophage activation by LPS is not affected by the 
ICAM-1 deficiency, whereas T cell activation by SEB is criti- 
cally diminished and leads to protection in D-Gal-sensitized 
mice. These results are in agreement with those obtained from 
experiments in which ICAM-l-deficient mice were infected 
with Listeria monocytogenes. These experiments revealed that 
the T cell-independent phase of the infection was unaffected 
in ICAM-l-deficient mice, whereas the T cell-dependent phase 
may occur at a slower rate in ICAM-1 mutant mice (Rogers, 
H.,  and E.  Unanue, personal communication). 
This study shows that ICAM-1 is critically involved in the 
massive T cell activation that occurs in sepsis  by gram-positive 
exotoxins. ICAM-1 also is involved in leukocyte-endothelial 
interactions,  which are central in the lethal shock induced 
by high doses of gram-negative  endotoxins. 
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